Xiaochun Zhang
Overview
Explore the profile of Xiaochun Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
376
Citations
4272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lan H, Zhu J, Hou H, Zhang C, Huo X, Zhang Y, et al.
Cell Commun Signal
. 2025 Mar;
23(1):137.
PMID: 40087780
Purpose: Limited treatment options exist for refractory ovarian cancer (OC) due to its poor response to immune therapies. Therefore, there is an urgent need to develop new effective treatment strategies....
2.
Zhang X, Xiang Z, Wang F, Pan X, Zhang Q, Wang P, et al.
EJNMMI Phys
. 2025 Mar;
12(1):18.
PMID: 40032742
Purpose: To explore the feasibility of reducing scan duration of N-NH myocardial perfusion imaging (MPI) using a total-body PET/CT scanner. Methods: Forty-five patients with known or suspected coronary artery disease...
3.
Zhang X, Jin Q, Li W, Pan C, Guo K, Yang X, et al.
EuroIntervention
. 2025 Mar;
21(5):e262-e271.
PMID: 40028730
Background: Despite the fact that morbidity and mortality rates significantly increase with tricuspid regurgitation (TR) severity, limited treatment options are available for treating severe TR. Aims: The single-arm, multicentre, prospective...
4.
Fan J, Lin D, Miao J, Weng Z, Qi Y, Zhan Z, et al.
Cardiology
. 2025 Feb;
:1-25.
PMID: 39999812
Background: Transcatheter aortic valve replacement (TAVR) has emerged as the recommended treatment for older patients with pure severe aortic regurgitation (PSAR). However, the efficacy of TAVR in younger patients with...
5.
Li M, Chen D, Fan J, Tian D, Zhang L, Zhang X, et al.
Respir Res
. 2025 Feb;
26(1):67.
PMID: 39988677
Aim: To evaluate the safety and efficacy of FreeFlow percutaneous atrial septal shunt device (manufactured by AOLIU Medical Technology Co., Ltd, Shanghai, China) in patients with refractory pulmonary arterial hypertension...
6.
Song Y, Lin D, Zhang X, Zhou D
BMC Cardiovasc Disord
. 2025 Feb;
25(1):97.
PMID: 39948446
Background: Ascending aortic perforation is a rare complication of the transseptal puncture procedure that often requires emergency management. Case Presentation: We report the case of a 53-year-old woman with severe...
7.
Zhao C, Zhang X, Zhang X, Zhao B, Yang Y, Lin M, et al.
Sci Rep
. 2025 Feb;
15(1):4791.
PMID: 39922960
This study aimed to evaluate the association between the total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C) ratio and the risk of osteoporosis in older adults. A cross-sectional analysis was conducted...
8.
Wang S, Yang D, Yuan C, Wu Y, Wang Q, Wu Y, et al.
Adv Biol (Weinh)
. 2025 Feb;
:e2400306.
PMID: 39912781
Traditional Chinese medicine (TCM) Yi-Fei-Jie-Du-Tang (YFJDT) has shown potential in lung cancer treatment. However, the mechanisms underlying the effects of YFJDT on lung cancer remain unclear. Bioinformatics analysis is conducted...
9.
Lin D, Zhang X, Pan W, Zhou D
J Am Coll Cardiol
. 2025 Jan;
85(3):e35.
PMID: 39843033
No abstract available.
10.
Chen C, Ma Y, Gao Y, Ge H, Zhang X
Hematology
. 2025 Jan;
30(1):2452701.
PMID: 39829399
Background: This study aimed to develop a prognostic model based on extracellular trap-related genes (NETRGs) for patients with cALL. Methods: Data from the TARGET-ALL-P2 and TARGET-ALL-P3 cohorts in the Genomic...